☰

Can Kucuk, Ph.D. - Publications

Affiliations: 
2012 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Pathology, Molecular Biology, Genetics
Tree Info Grants Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Esmeray Sönmez E, Hatipoğlu T, Kurşun D, Hu X, Akman B, Yuan H, Erşen Danyeli A, Alacacıoğlu İ, Özkal S, Olgun A, Erdağ TK, You H, Küçük C. Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma. Cells. 11. PMID 36359790 DOI: 10.3390/cells11213394  0.424
2020 Akman B, Hu X, Liu X, Hatipoğlu T, You H, Chan WC, Küçük C. PRDM1 decreases sensitivity of human NK cells to IL2-induced cell expansion by directly repressing CD25 (IL2RA). Journal of Leukocyte Biology. PMID 33145806 DOI: 10.1002/JLB.2A0520-321RR  0.521
2020 Küçük C, Wei L, You H. Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy. Frontiers in Oncology. 10: 1276. PMID 32850389 DOI: 10.3389/fonc.2020.01276  0.359
2020 Küçük C, Wang J, Xiang Y, You H. Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications. Therapeutic Advances in Medical Oncology. 12: 1758835919900856. PMID 32127923 DOI: 10.1177/1758835919900856  0.42
2020 Esmeray E, Küçük C. Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring. Turkish Journal of Biology = Turk Biyoloji Dergisi. 44: 1-14. PMID 32123491 DOI: 10.3906/Biy-1908-23  0.458
2019 Küçük C. Genetic susceptibility to natural killer T-cell lymphoma. The Lancet. Oncology. PMID 31879221 DOI: 10.1016/S1470-2045(19)30820-4  0.435
2019 Kurşun D, Küçük C. Systematic analysis of the frequently amplified 2p15-p16.1 locus reveals PAPOLG as a potential proto-oncogene in follicular and transformed follicular lymphoma. Turkish Journal of Biology = Turk Biyoloji Dergisi. 43: 124-132. PMID 31410080 DOI: 10.3906/Biy-1810-2  0.391
2018 Kucuk C, C Chan W. Selective expression of KIR2DL4 for improved diagnosis and as a potential therapeutic target in natural killer/T cell lymphoma Global Vaccines and Immunology. 3. DOI: 10.15761/GVI.1000132  0.347
2018 Akman B, Kursun D, Hatipoglu T, Hu X, Chan WC, Kucuk C. CD25 (IL2RA) Is a Direct Transcriptional Target of PRDM1 in Activated Human Natural Killer Cells Blood. 132: 3724-3724. DOI: 10.1182/Blood-2018-99-113460  0.341
2017 Wan Y, He D, Ye Y, Zhang W, Zhao S, Long Y, Chen M, Küçük C. Primary cardiac diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression in an immunocompetent Chinese elderly woman. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 31: 54-56. PMID 28985492 DOI: 10.1016/J.Carpath.2017.07.006  0.426
2017 Baytak E, Gong Q, Akman B, Yuan H, Chan WC, Küçük C. Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 39: 1010428317701648. PMID 28468592 DOI: 10.1177/1010428317701648  0.605
2017 Hu X, Baytak E, Li J, Akman B, Okay K, Hu G, Scuto A, Zhang W, Küçük C. The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma. Leukemia Research. 54: 30-38. PMID 28095352 DOI: 10.1016/J.Leukres.2017.01.001  0.468
2016 Küçük C, Hu X, Gong Q, Jiang B, Cornish A, Gaulard P, McKeithan T, Chan WC. Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma. The American Journal of Pathology. PMID 27060228 DOI: 10.1016/J.Ajpath.2016.02.011  0.613
2016 Gao LM, Zhao S, Liu WP, Zhang WY, Li GD, Küçük C, Hu XZ, Chan WC, Tang Y, Ding WS, Yan JQ, Yao WQ, Wang JC. Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue Sites. The American Journal of Surgical Pathology. PMID 26975038 DOI: 10.1097/Pas.0000000000000634  0.556
2015 Küçük C, Hu X, McKeithan T, Chan WC. Lack of evidence that HACE1 is not a tumor suppressor gene in NKTCL: to the editor-in-chief. The American Journal of Pathology. 185: 1167-8. PMID 25794710 DOI: 10.1016/J.Ajpath.2014.10.028  0.511
2015 Küçük C, Hu X, Jiang B, Klinkebiel D, Geng H, Gong Q, Bouska A, Iqbal J, Gaulard P, McKeithan TW, Chan WC. Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1699-711. PMID 25614448 DOI: 10.1158/1078-0432.Ccr-14-1216  0.601
2015 Küçük C, Jiang B, Hu X, Zhang W, Chan JK, Xiao W, Lack N, Alkan C, Williams JC, Avery KN, Kavak P, Scuto A, Sen E, Gaulard P, Staudt L, et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells. Nature Communications. 6: 6025. PMID 25586472 DOI: 10.1038/Ncomms7025  0.603
2014 Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Zhang W, Kucuk C, Rinaldi A, Bertoni F, Fitzgibbon J, Fu K, Weisenburger DD, Greiner TC, et al. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood. 123: 1681-90. PMID 24037725 DOI: 10.1182/Blood-2013-05-500595  0.317
2013 Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, Wang HY, Cheng JX, Bacon CM, Delabie J, Ranheim E, Kucuk C, Hu X, Weisenburger DD, Jaffe ES, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood. 122: 3599-606. PMID 24009234 DOI: 10.1182/Blood-2013-07-512830  0.576
2013 Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, Lim MS, Piva R, Barreca A, Pellegrino E, Spaccarotella E, Lachel CM, Kucuk C, Jiang CS, Hu X, et al. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood. 122: 2083-92. PMID 23801630 DOI: 10.1182/Blood-2012-08-447375  0.458
2013 Küçük C, Hu X, Iqbal J, Gaulard P, Klinkebiel D, Cornish A, Dave BJ, Chan WC. HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms. The American Journal of Pathology. 182: 49-55. PMID 23142381 DOI: 10.1016/J.Ajpath.2012.09.012  0.627
2013 Kucuk C, Hu X, Jiang B, Gaulard P, Klinkebiel D, Geng H, Bouska A, Iqbal J, McKeithan T, Chan WC. Global Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes In Natural Killer Cell Lymphomas Blood. 122: 1262-1262. DOI: 10.1182/Blood.V122.21.1262.1262  0.504
2012 Cairns RA, Iqbal J, Lemonnier F, Kucuk C, De Leval L, Jais JP, Parrens M, Martin A, Xerri L, Brousset P, Chan LC, Chan WC, Gaulard P, Mak TW. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma Blood. 119: 1901-1903. PMID 22215888 DOI: 10.1182/Blood-2011-11-391748  0.434
2012 Bouska A, McKeithan T, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Liu Z, Kucuk C, Bertoni F, Rinaldi A, Fitzgibbon J, Fu K, Weisenburger DD, Greiner TC, et al. Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma. Blood. 120: 2648-2648. DOI: 10.1182/Blood.V120.21.2648.2648  0.375
2011 Iqbal J, Weisenburger DD, Chowdhury A, Tsai MY, Srivastava G, Greiner TC, Kucuk C, Deffenbacher K, Vose J, Smith L, Au WY, Nakamura S, Seto M, Delabie J, Berger F, et al. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia. 25: 348-58. PMID 21052088 DOI: 10.1038/Leu.2010.255  0.564
2011 Iqbal J, Weisenburger DD, Chowdhury A, Tsai MY, Srivastava G, Greiner TC, Kucuk C, Deffenbacher K, Vose JM, Smith LM, Au WY, Nakamura S, Seto M, Delabie J, Berger F, et al. Erratum: Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro (Leukemia (2011) 25 (348-358) DOI:10.1038/leu.2010.255) Leukemia. 25. DOI: 10.1038/Leu.2011.102  0.455
2010 Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C, Geng H, Deffenbacher K, Smith L, Dybkaer K, Nakamura S, Seto M, Delabie J, Berger F, Loong F, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 115: 1026-36. PMID 19965671 DOI: 10.1182/Blood-2009-06-227579  0.64
2009 Iqbal J, Kucuk C, Deleeuw RJ, Srivastava G, Tam W, Geng H, Klinkebiel D, Christman JK, Patel K, Cao K, Shen L, Dybkaer K, Tsui IF, Ali H, Shimizu N, et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia. 23: 1139-51. PMID 19194464 DOI: 10.1182/Blood.V112.11.3792.3792  0.491
2009 Iqbal J, Weisenburger DD, Chowdhury A, Srivastava G, Greiner TC, Deffenbacher KE, Kucuk C, Vose JM, Au W, Nakamura S, Seto M, Delabie J, Berger F, Loong F, Ko Y, et al. NK-Cell Lymphoma Shares Strikingly Similar Molecular Features with a Distinct Set of γδ T-Cell Lymphoma and Identification of Aurora Kinase A Inhibitor as a Novel Therapeutic Agent. Blood. 114: 313-313. DOI: 10.1182/Blood.V114.22.313.313  0.549
2008 Kucuk C, Iqbal J, deLeeuw RJ, Srivastava G, Tam W, Klinkebiel D, Christman JK, Shen L, Dybkaer K, Au WY, Lam WL, Chan WC. Genomic Analyses Reveal Global Functional Alterations That Promote Tumor Growth and Novel Tumor Suppressor Genes in Natural Killer-Cell Malignancies Blood. 112: 3792-3792. DOI: 10.1182/blood.v112.11.3792.3792  0.409
2008 Iqbal J, Weisenburger D, Greiner TC, Nakamura S, Vose JM, Seto M, Delabie J, Berger F, Loong F, Au W, Ko Y, Sng I, Smith LM, Kucuk C, Geng H, et al. Molecular Signatures to Improve Diagnosis, Prognostication and Identification of Oncogenic Pathways in Peripheral T and NK Cell Lymphoma. Blood. 112: 3339-3339. DOI: 10.1182/Blood.V112.11.3339.3339  0.549
2007 Iqbal J, Joshi S, Patel KN, Javed SI, Kucuk C, Aabida A, d'Amore F, Fu K. Clinical implication of genome-wide profiling in diffuse large B-cell lymphoma and other subtypes of B-cell lymphoma. Indian Journal of Cancer. 44: 72-86. PMID 17938484 DOI: 10.4103/0019-509X.35814  0.416
Show low-probability matches.